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Background:  Despite interventions aimed at risk factor reduction of atherosclerosis, the mortality of peripheral vascular disease (PVD) patients 
persists with a long term mortality rate of approximately 50%. The impact of elevated body mass index (BMI) and chronic kidney disease (CKD) on 
mortality in patients with PVD is not clear. We aim to determine the outcomes of PVD in patients with elevated BMI and CKD.
Methods:  We retrospectively analyzed 303 consecutive patients who underwent either endovascular or surgical procedures to treat PVD at our 
institution between January 1, 2006 and December 31, 2007. P value was determined using the Fishers exact test and Chi square analysis. Kaplan 
Meier regression analysis was used to determine mortality differences
Results:  Out of the 303 patients examined, 86 patients (28.38%) were obese (BMI>30). Obesity was not significantly associated with increased 
rates of mortality at 30 days (p = 0.38), 1 year (p = 0.41) or 3 years (p = 0.58). One hundred and twenty nine PVD patients had low Glomerular 
filtration rate (GFR) < 60ml/min/1.72m2. PVD patients with low GFR had significantly higher rates of death at 30 days (p = 0.016), 1 year (p = 
0.001) and 3 years (p < 0.001) than patients with normal GFR. There was no significant difference in other risk factors between the two groups of 
obese versus non obese and patients with GFR <60 versus GFR>60ml/min/1.72m2.
Conclusions:  Obesity was not an independent predictor of mortality in PVD patients. However, chronic kidney disease with GFR <60 was a 
predictor of increased short term (30 days) and long term (1 and 3 year) mortality.
